The Trump administration is considering a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, the ...

The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...

The Washington Post editorial board argued a federal judge's ruling against congressional Medicaid restrictions on abortion ...

Proposed experiment would allow states and Medicare drug plans to cover GLP-1 drugs like Ozempic and Wegovy for obesity, The ...

The Washington Post reported the CMS is considering a plan that could allow Medicare plans to pay for the drugs.

Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural ...

The Trump administration is planning an experiment to cover weight-loss drugs under Medicare and Medicaid, the Washington Post reported on Friday, citing documents from the Centers for Medicare and ...

The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of obesity ...

UnitedHealth Group says it is cooperating with federal criminal and civil investigations involving its market-leading ...

Medicare Bills Pass In Congress Prescription Drug Benefit Is Key To Biggest Changes in 38 Years June 26, 2003 More than 22 years ago Summary By Amy Goldstein ...